Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dentalpoint was a Swiss dental medical device company focused on metal-free ceramic dental implants marketed under the ZERAMEX brand. The company developed and commercialized two-piece zirconia implant systems for tooth replacement and oral rehabilitation, positioning its products around aesthetics, biocompatibility, and metal-free implantology. Its portfolio included commercial implant systems such as ZERAMEX XT, with older ZERAMEX P6 and ZERAMEX T systems later phased out. Dentalpoint was acquired by CeramTec on January 4, 2021, and in 2024 its successor entity was renamed CeramTec Switzerland LLC while continuing the ZERAMEX business from Switzerland.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dentalpoint.